151 related articles for article (PubMed ID: 35949721)
1. The clinical and histological characteristics of patients with biopsy-proven non-alcoholic fatty liver disease in the absence of insulin resistance.
Demirtas CO; Sapmaz A; Gurel BA; Kizmaz H; Ulu T; Karaketir SG; Hidiroglu S; Yilmaz Y
Hepatol Forum; 2020 Sep; 1(3):101-108. PubMed ID: 35949721
[TBL] [Abstract][Full Text] [Related]
2. The independent predictors of non-alcoholic steatohepatitis and its individual histological features.: Insulin resistance, serum uric acid, metabolic syndrome, alanine aminotransferase and serum total cholesterol are a clue to pathogenesis and candidate targets for treatment.
Ballestri S; Nascimbeni F; Romagnoli D; Lonardo A
Hepatol Res; 2016 Oct; 46(11):1074-1087. PubMed ID: 26785389
[TBL] [Abstract][Full Text] [Related]
3. Clinical spectrum of non-alcoholic fatty liver disease in diabetic and non-diabetic patients.
Goh GB; Pagadala MR; Dasarathy J; Unalp-Arida A; Sargent R; Hawkins C; Sourianarayanane A; Khiyami A; Yerian L; Pai RK; Dasarathy S; McCullough AJ
BBA Clin; 2015 Jun; 3():141-5. PubMed ID: 26675585
[TBL] [Abstract][Full Text] [Related]
4. The Relationship between Insulin Resistance and Liver Damage in non-alcoholic Fatty Liver Patients.
Cetin EG; Demir N; Sen I
Sisli Etfal Hastan Tip Bul; 2020; 54(4):411-415. PubMed ID: 33364879
[TBL] [Abstract][Full Text] [Related]
5. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of biopsy-proven non-alcoholic fatty liver disease in severely obese subjects without metabolic syndrome.
Qureshi K; Abrams GA
Clin Obes; 2016 Apr; 6(2):117-23. PubMed ID: 26856683
[TBL] [Abstract][Full Text] [Related]
7. Ethnicity and nonalcoholic fatty liver disease.
Bambha K; Belt P; Abraham M; Wilson LA; Pabst M; Ferrell L; Unalp-Arida A; Bass N;
Hepatology; 2012 Mar; 55(3):769-80. PubMed ID: 21987488
[TBL] [Abstract][Full Text] [Related]
8. Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis.
Koo BK; Kim D; Joo SK; Kim JH; Chang MS; Kim BG; Lee KL; Kim W
J Hepatol; 2017 Jan; 66(1):123-131. PubMed ID: 27599824
[TBL] [Abstract][Full Text] [Related]
9. Histopathological differences utilizing the nonalcoholic fatty liver disease activity score criteria in diabetic (type 2 diabetes mellitus) and non-diabetic patients with nonalcoholic fatty liver disease.
Puchakayala BK; Verma S; Kanwar P; Hart J; Sanivarapu RR; Mohanty SR
World J Hepatol; 2015 Nov; 7(25):2610-8. PubMed ID: 26557954
[TBL] [Abstract][Full Text] [Related]
10. Biopsy Proven Fibrosis in Non-Alcoholic Fatty Liver Disease: An Analysis of Risk Factors.
Pattnaik K; Bhuyan P; Singh A; Singh SP; Nath P; Kar S; Misra B; Rath J
J Clin Exp Hepatol; 2018 Dec; 8(4):367-374. PubMed ID: 30563997
[TBL] [Abstract][Full Text] [Related]
11. FICK-3 Score Combining Fibrosis-4, Insulin Resistance and Cytokeratin-18 in Predicting Non-alcoholic Steatohepatitis in NAFLD Egyptian Patients.
Mohammed MA; Omar NM; Mohammed SA; Amin AM; Gad DF
Pak J Biol Sci; 2019 Jan; 22(10):457-466. PubMed ID: 31930835
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of steatosis and insulin resistance in patients with chronic hepatitis B compared with chronic hepatitis C and non-alcoholic fatty liver disease.
Pais R; Rusu E; Zilisteanu D; Circiumaru A; Micu L; Voiculescu M; Poynard T; Ratziu V
Eur J Intern Med; 2015 Jan; 26(1):30-6. PubMed ID: 25553983
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and risk factors for biopsy-proven non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in a prospective cohort of adult patients with gallstones.
García-Monzón C; Vargas-Castrillón J; Porrero JL; Alonso MT; Bonachía O; Castillo MJ; Marcos A; Quirós E; Ramos B; Sánchez-Cabezudo C; Villar S; Sáez A; Rodríguez de Cía J; del Pozo E; Vega-Piris L; Soto-Fernández S; Lo Iacono O; Miquilena-Colina ME
Liver Int; 2015 Aug; 35(8):1983-91. PubMed ID: 25708133
[TBL] [Abstract][Full Text] [Related]
14. Insulin resistance is related with liver fibrosis in type 2 diabetic patients with non-alcoholic fatty liver disease proven biopsy and Mediterranean diet pattern as a protective factor.
Aller R; Sigüenza R; Pina M; Laserna C; Antolín B; Burgueño B; Durà M; Izaola O; Primo D; de Luis DA
Endocrine; 2020 Jun; 68(3):557-563. PubMed ID: 32239453
[TBL] [Abstract][Full Text] [Related]
15. IS HOMEOSTASIS MODEL ASSESSMENT FOR INSULIN RESISTANCE >2.5 A DISTINGUISHED CRITERIA FOR METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE IDENTIFICATION?
Barreto BFM; Punaro GR; Elias MC; Parise ER
Arq Gastroenterol; 2022; 59(3):402-407. PubMed ID: 36102439
[TBL] [Abstract][Full Text] [Related]
16. Histopathological differences in patients with biopsy-proven non-alcoholic fatty liver disease with and without type 2 diabetes.
Aller de la Fuente R; Mora Cuadrado N; Tafur C; López Gómez JJ; Gómez de la Cuesta S; García Sánchez MC; Antolin Melero B; de Luis Román DA
Endocrinol Diabetes Nutr (Engl Ed); 2018; 65(6):354-360. PubMed ID: 29477355
[TBL] [Abstract][Full Text] [Related]
17. Fatty liver disease: predictors of nonalcoholic steatohepatitis and gallbladder disease in morbid obesity.
Liew PL; Lee WJ; Wang W; Lee YC; Chen WY; Fang CL; Huang MT
Obes Surg; 2008 Jul; 18(7):847-53. PubMed ID: 18459024
[TBL] [Abstract][Full Text] [Related]
18. IMPACT OF TYPE 2 DIABETES ON NONALCOHOLIC STEATOHEPATITIS AND ADVANCED FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE.
Bian H; Zhu X; Xia M; Yan H; Chang X; Hu X; Pan B; Guo W; Li X; Gao X
Endocr Pract; 2020 Apr; 26(4):444-453. PubMed ID: 31968197
[No Abstract] [Full Text] [Related]
19. Metabolic syndrome and liver histology in paediatric non-alcoholic steatohepatitis.
Manco M; Marcellini M; Devito R; Comparcola D; Sartorelli MR; Nobili V
Int J Obes (Lond); 2008 Feb; 32(2):381-7. PubMed ID: 18087267
[TBL] [Abstract][Full Text] [Related]
20. The value of different insulin resistance indices in assessment of non-alcoholic fatty liver disease in overweight/obese children.
El-Karaksy HM; El-Raziky MS; Fouad HM; Anwar GM; El-Mougy FM; El-Koofy NM; El-Hennawy AM
Diabetes Metab Syndr; 2015; 9(2):114-9. PubMed ID: 25470627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
